In keeping with these findings, we further found that ectopic expression of SPOP WT, but not cancer-derived mutants, could promote the degradation of HDAC6 in cells in a dose-dependent manner (Figure 5E), which largely was due to deficiency in promoting the poly-ubiquitination of HDAC6 in cells (Figure 5F). The gene discussed is HDAC6; the disease is cancer.